<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">100953980</journal-id>
<journal-id journal-id-type="pubmed-jr-id">21906</journal-id>
<journal-id journal-id-type="nlm-ta">ALTEX</journal-id>
<journal-id journal-id-type="iso-abbrev">ALTEX</journal-id>
<journal-title-group>
<journal-title>ALTEX</journal-title>
</journal-title-group>
<issn pub-type="ppub">1868-596X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29485663</article-id>
<article-id pub-id-type="pmc">6545888</article-id>
<article-id pub-id-type="doi">10.14573/altex.1712081</article-id>
<article-id pub-id-type="manuscript">EPAPA1527783</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Recommendation on test readiness criteria for new approach methods
(NAM) in toxicology: exemplified for developmental neurotoxicity
(DNT)</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Bal-Price</surname>
<given-names>Anna</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hogberg</surname>
<given-names>Helena T.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Crofton</surname>
<given-names>Kevin M.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Daneshian</surname>
<given-names>Mardas</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>FitzGerald</surname>
<given-names>Rex E.</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fritsche</surname>
<given-names>Ellen</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Heinonen</surname>
<given-names>Tuula</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bennekou</surname>
<given-names>Susanne Hougaard</given-names>
</name>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Klima</surname>
<given-names>Stefanie</given-names>
</name>
<xref ref-type="aff" rid="A16">16</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Piersma</surname>
<given-names>Aldert H.</given-names>
</name>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sachana</surname>
<given-names>Magdalini</given-names>
</name>
<xref ref-type="aff" rid="A10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shafer</surname>
<given-names>Timothy J.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Terron</surname>
<given-names>Andrea</given-names>
</name>
<xref ref-type="aff" rid="A11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Monnet-Tschudi</surname>
<given-names>Florianne</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A12">12</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Viviani</surname>
<given-names>Barbara</given-names>
</name>
<xref ref-type="aff" rid="A13">13</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Waldmann</surname>
<given-names>Tanja</given-names>
</name>
<xref ref-type="aff" rid="A16">16</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Westerink</surname>
<given-names>Remco H.S.</given-names>
</name>
<xref ref-type="aff" rid="A14">14</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wilks</surname>
<given-names>Martin F.</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Witters</surname>
<given-names>Hilda</given-names>
</name>
<xref ref-type="aff" rid="A15">15</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zurich</surname>
<given-names>Marie-Gabrielle</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A12">12</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Leist</surname>
<given-names>Marcel</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A16">16</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>European Commission, Joint Research Centre (EC JRC), Ispra
(VA), Italy</aff>
<aff id="A2"><label>2</label>Center for Alternatives to Animal Testing (CAAT), Johns
Hopkins University, Baltimore, MD, USA</aff>
<aff id="A3"><label>3</label>National Centre for Computational Toxicology, US EPA, RTP,
Washington, NC, USA</aff>
<aff id="A4"><label>4</label>Center for Alternatives to Animal Testing, CAAT-Europe,
University of Konstanz, Konstanz, Germany</aff>
<aff id="A5"><label>5</label>Swiss Centre for Human Applied Toxicology, SCAHT,
University of Basel, Switzerland</aff>
<aff id="A6"><label>6</label>IUF – Leibniz Research Institute for Environmental
Medicine &amp; Heinrich-Heine-University, Düsseldorf, Germany</aff>
<aff id="A7"><label>7</label>Finnish Centre for Alternative Methods (FICAM), University
of Tampere, Tampere, Finland</aff>
<aff id="A8"><label>8</label>The Danish Environmental Protection Agency, Copenhagen,
Denmark</aff>
<aff id="A9"><label>9</label>RIVM, National Institute for Public Health and the
Environment, Bilthoven, and Institute for Risk Assessment Sciences, Utrecht
University, Utrecht, The Netherlands</aff>
<aff id="A10"><label>10</label>Organisation for Economic Co-operation and Development
(OECD), 2 rue André Pascal, 75775 Paris Cedex 16, France</aff>
<aff id="A11"><label>11</label>European Food Safety Authority, Parma, Italy</aff>
<aff id="A12"><label>12</label>Department of Physiology, University of Lausanne,
Lausanne, Switzerland</aff>
<aff id="A13"><label>13</label>Department of Pharmacological and Biomolecular Sciences,
University of Milan</aff>
<aff id="A14"><label>14</label>Neurotoxicology Research Group, Institute for Risk
Assessment Sciences (IRAS), Faculty of Veterinary Medicine, Utrecht University,
Utrecht, The Netherlands</aff>
<aff id="A15"><label>15</label>VITO, Flemish Institute for Technological Research, Unit
Environmental Risk and Health, Mol, Belgium</aff>
<aff id="A16"><label>16</label>In vitro Toxicology and Biomedicine, Department of
Biology, University of Konstanz</aff>
<author-notes>
<corresp id="CR1"><bold>To whom correspondence should be addressed:</bold> Tanja
Waldmann, University of Konstanz, D-78457 Konstanz, Germany,
<email>tanja.waldmann@uni-konstanz.de</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>1</day>
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>23</day>
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>03</day>
<month>6</month>
<year>2019</year>
</pub-date>
<volume>35</volume>
<issue>3</issue>
<fpage>306</fpage>
<lpage>352</lpage>
<!--elocation-id from pubmed: 10.14573/altex.1712081-->
<abstract id="ABS1">
<p id="P1">Multiple non-animal-based test methods have never been formally
validated. In order to use such new approach methods (NAMs) in a regulatory
context, criteria to define their readiness are necessary. The field of
developmental neurotoxicity (DNT) testing is used to exemplify the application
of readiness criteria. The costs and number of untested chemicals are
overwhelming for in vivo DNT testing. Thus, there is a need for inexpensive,
high-throughput NAMs to obtain initial information on potential hazards, and to
allow prioritization for further testing. A background on the regulatory and
scientific status of DNT testing is provided showing different types of test
readiness levels, depending on the intended use of data from NAMs. Readiness
criteria, compiled during a stakeholder workshop that united scientists from
academia, industry and regulatory authorities, are presented. An important step
beyond the listing of criteria was the suggestion of a preliminary scoring
scheme. On this basis a (semi)-quantitative analysis process was assembled on
test readiness of 17 NAMs with respect to various uses (e.g.,
prioritization/screening, risk assessment). The scoring results suggest that
several assays are currently at high readiness levels. Therefore, suggestions
are made on how DNT NAMs may be assembled into an integrated approach to testing
and assessment (IATA). In parallel, the testing state in these assays was
compiled for more than 1000 compounds. Finally, a vision is presented on how
further NAM development may be guided by knowledge of signaling pathways
necessary for brain development, DNT pathophysiology, and relevant adverse
outcome pathways (AOP).</p>
</abstract>
<kwd-group>
<kwd>developmental neurotoxicity</kwd>
<kwd>in vitro testing</kwd>
<kwd>zebrafish embryo test</kwd>
<kwd>stem cells</kwd>
<kwd>regulatory toxicology</kwd>
<kwd>toxicity screening</kwd>
<kwd>quality assurance</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>